Hospital & Healthcare Services · Founded 2011 · www.looksclinic.in · BSE 534422 · · ISIN INE204N01013
No Notes Added Yet
Business
Looks Health Services Ltd. operates within the Hospital & Healthcare Services sector in India. While specific detailed operations are not provided, companies in this sector typically offer a range of medical, diagnostic, and wellness services. Given the name "Looks Health Services," it likely specializes in or has a significant focus on cosmetic, aesthetic, dermatological, or wellness-oriented healthcare services, alongside potentially general healthcare offerings. The core business model involves providing these services to patients, generating revenue through consultation fees, procedure charges, treatment packages, and sale of related products.
Revenue Mix
Specific segment breakdowns or revenue mix details are not publicly available within the provided information. However, based on the company's name and industry, potential segments could include cosmetic dermatology, plastic surgery, hair restoration, anti-aging treatments, general wellness programs, and potentially non-invasive aesthetic procedures. Without financial reports, precise contributions from these potential segments cannot be determined.
Industry
The Hospital & Healthcare Services industry in India is large, diverse, and growing, characterized by a mix of large corporate hospital chains, standalone specialty clinics, and unorganized local players. It is also highly fragmented, particularly in niche areas. Looks Health Services Ltd. likely positions itself in the specialized segment of aesthetic, cosmetic, and wellness healthcare services. Its standing against peers would depend on its geographical footprint, brand recognition, quality of practitioners, range of specialized services, and pricing strategy within this competitive landscape, which also includes various smaller clinics and individual practitioners.
MOAT
For a company like Looks Health Services, potential competitive advantages could include:
Brand Reputation: A strong brand name associated with quality and trust in aesthetic and wellness services can attract and retain clients.
Niche Specialization: Focusing on specific high-demand cosmetic or wellness treatments can create expertise and market leadership in those areas.
Skilled Practitioners: Access to and retention of highly skilled and reputable doctors and technicians in specialized fields.
Geographic Concentration: Dominance in certain urban markets with multiple clinics providing convenience and accessibility.
Customer Loyalty/Repeat Business: High satisfaction in appearance-related treatments often leads to recurring visits and referrals.
Growth Drivers
Key factors that can drive growth for Looks Health Services over the next 3-5 years include:
Rising Disposable Incomes: Increasing affluence in India fuels demand for elective cosmetic and wellness treatments.
Growing Health and Appearance Consciousness: Greater awareness and desire for aesthetic improvements and well-being among the populace.
Urbanization and Lifestyle Changes: Urban centers typically drive higher demand for specialized healthcare and aesthetic services.
Technological Advancements: Adoption of new, less invasive, and more effective cosmetic and medical technologies can attract new patients.
Expansion: Opening new clinics in high-demand urban and tier-2 cities, or expanding service offerings to tap into broader healthcare needs.
Risks
Intense Competition: The aesthetic and wellness market is highly competitive with numerous local players, independent clinics, and potential entry of larger hospital chains.
Regulatory Changes: Evolving regulations related to medical procedures, advertising, and service standards in the healthcare sector.
Talent Retention: Attracting and retaining qualified and experienced doctors and medical staff, particularly in specialized fields.
Reputational Risk: Negative publicity from unsuccessful procedures, patient dissatisfaction, or ethical concerns can significantly impact business.
Capital Intensity: Expansion and adoption of new technologies may require significant capital expenditure.
Economic Downturns: As many aesthetic services are elective, they can be sensitive to economic slowdowns affecting consumer discretionary spending.
Management & Ownership
Details on specific promoters, management quality assessments, or the detailed ownership structure for Looks Health Services Ltd. are not provided in the given information. In India, many companies, especially smaller and mid-sized ones, are promoter-driven, meaning founding families or individuals hold significant stakes and exert substantial influence over strategic and operational decisions.
Outlook
Looks Health Services Ltd. operates in a promising segment of the Indian healthcare market, driven by favorable demographics and rising consumer aspirations for wellness and aesthetics. The potential for growth is significant, fueled by increasing disposable incomes and greater health consciousness. However, the sector is also highly competitive and prone to reputational risks. Success will hinge on maintaining service quality, effectively managing its brand, adopting new technologies, and prudently expanding its footprint. The company's ability to differentiate itself through specialized expertise and patient outcomes will be crucial in navigating the fragmented market and competing effectively against both small and large players.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit | 0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Provision for Tax | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjustments | -0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted Earnings Per Share | -0 | -0 | -0.1 | -0 | 0.2 | 0 | 0 | 0 | 0 | 0 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 2 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 3 | 2 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
| Total Expenditure | 2 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Operating Profit | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | -0 | 0 | 0 | 0 |
| Provision for Tax | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
| Profit After Tax | 0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | -0 | 0 | 0 | 0 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | -0 | 0 | 0 | 0 |
| Adjusted Earnings Per Share | 0.1 | 0 | 0.3 | 0.2 | -0 | -0.2 | 0 | -0.2 | -0 | 0 | 0 | 0 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | 0% | 0% | -100% |
| Operating Profit CAGR | 0% | 0% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 94% | 22% | -16% | -4% |
| ROE Average | 0% | 0% | -0% | 0% |
| ROCE Average | 0% | 0% | -0% | 0% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Total Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 15 | 23 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 16 |
| Fixed Assets | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Other Non-Current Assets | 13 | 21 | 13 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 15 |
| Total Current Assets | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Total Assets | 15 | 23 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 16 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow from Operating Activities | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1 | 1 |
| Cash Flow from Investing Activities | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | -1 |
| Cash Flow from Financing Activities | 0 | -0 | -0 | -1 | 0 | -0 | 0 | 0 | 0 | 0 | 1 |
| Net Cash Inflow / Outflow | 0 | -0 | 0 | -0 | -0 | 0 | 0 | 0 | -0 | 0 | 1 |
| Closing Cash & Cash Equivalent | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.08 | 0.01 | 0.29 | 0.23 | -0.02 | -0.16 | 0.03 | -0.15 | -0.02 | 0.02 | 0.02 |
| CEPS(Rs) | 0.32 | 0.34 | 0.49 | 0.4 | 0.21 | 0.05 | 0.17 | -0.02 | 0.12 | 0.16 | 0.16 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 13.74 | 13.84 | 14.13 | 14.36 | 14.25 | 14.24 | 14.27 | 14.11 | 14.1 | 14.12 | 14.14 |
| Core EBITDA Margin(%) | -39.03 | -15.78 | -6.24 | -11.07 | -45.07 | -2913.7 | 0 | -5562.67 | 0 | -55.71 | 43.87 |
| EBIT Margin(%) | 13.36 | 0.95 | 20.35 | 30.07 | 1.55 | -560.27 | 0 | -1364 | 0 | 7.32 | 8.35 |
| Pre Tax Margin(%) | 12.55 | 0.41 | 19.78 | 28.74 | -1.95 | -691.78 | 0 | -1364 | 0 | 7.32 | 8.12 |
| PAT Margin (%) | 5.65 | 0.34 | 19.87 | 20.69 | -2.14 | -1182.19 | 0 | -2128 | 0 | 6.06 | 6.06 |
| Cash Profit Margin (%) | 22.2 | 20.21 | 33.39 | 37.14 | 28.49 | 345.21 | 0 | -237.33 | 0 | 41.96 | 42.58 |
| ROA(%) | 0.58 | 0.03 | 1.59 | 1.55 | -0.11 | -1.14 | 0.21 | -1.07 | -0.12 | 0.16 | 0.15 |
| ROE(%) | 0.6 | 0.04 | 2.08 | 1.58 | -0.11 | -1.15 | 0.21 | -1.07 | -0.12 | 0.16 | 0.16 |
| ROCE(%) | 1.42 | 0.09 | 1.65 | 2.3 | 0.08 | -0.55 | 0.26 | -0.69 | -0.16 | 0.2 | 0.22 |
| Receivable days | 2.32 | 2.63 | 3.87 | 0 | 0 | 0 | 0 | 0 | 0 | 365 | 0 |
| Inventory Days | 34.43 | 15.84 | 9.1 | 7.22 | 1.14 | 0 | 0 | 0 | 0 | 0 | 0 |
| Payable days | 215.71 | 330.57 | 267.6 | 295.42 | 366.22 | 595.53 | 0 | 0 | 0 | 0 | 0 |
| PER(x) | 147.59 | 2894.74 | 0 | 31.88 | 0 | 0 | 369.41 | 0 | 0 | 203.51 | 295.98 |
| Price/Book(x) | 0.88 | 1.19 | 0 | 0.5 | 0 | 0.44 | 0.79 | 0.27 | 0.3 | 0.33 | 0.47 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 8.17 | 14.57 | 6.45 | 6.5 | 13.51 | 442.94 | 0 | 509.95 | 0 | 11.57 | 14.87 |
| EV/Core EBITDA(x) | 27.33 | 69.97 | 19.04 | 13.96 | 58.29 | 44.26 | 64.45 | 101.99 | 36.65 | 26.76 | 33.13 |
| Net Sales Growth(%) | -31.97 | 15.14 | -12.66 | -25.47 | -32.04 | -98.12 | -100 | 0 | -100 | 0 | -1.7 |
| EBIT Growth(%) | 245.42 | -91.83 | 1773.69 | 10.16 | -96.51 | -781.51 | 147.56 | -362.98 | 76.93 | 222.46 | 12.11 |
| PAT Growth(%) | 153.52 | -93.05 | 4992.84 | -22.4 | -107.01 | -940.76 | 118.48 | -600.31 | 88.91 | 235.03 | -1.67 |
| EPS Growth(%) | 153.51 | -93.05 | 4991.56 | -22.4 | -107.01 | -940.88 | 118.49 | -600 | 88.88 | 234.91 | -1.75 |
| Debt/Equity(x) | 0 | 0.58 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 0.83 | 1.02 | 2.78 | 0.89 | 0.99 | 12.1 | 7.9 | 67.3 | 10.75 | 6.05 | 2.98 |
| Quick Ratio(x) | 0.57 | 0.9 | 2.63 | 0.88 | 0.97 | 12.1 | 7.9 | 67.3 | 10.75 | 6.05 | 2.98 |
| Interest Cover(x) | 16.44 | 1.75 | 35.81 | 22.62 | 0.44 | -4.26 | 389 | 0 | 0 | 0 | 36 |
| Total Debt/Mcap(x) | 0 | 0.48 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 20.21 | 20.21 | 20.21 | 20.21 | 20.21 | 13.31 | 10.38 | 0 | 0 | 0 |
| FII | 0 | 0 | 0 | 0 | 0 | 6.93 | 9.31 | 16.99 | 16.99 | 16.99 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 79.79 | 79.79 | 79.79 | 79.79 | 79.79 | 79.76 | 80.31 | 83.01 | 83.01 | 83.01 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.14 | 0.11 | 0 | 0 | 0 |
| FII | 0 | 0 | 0 | 0 | 0 | 0.07 | 0.1 | 0.18 | 0.18 | 0.18 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.84 | 0.84 | 0.84 | 0.84 | 0.84 | 0.84 | 0.84 | 0.87 | 0.87 | 0.87 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.05 | 1.05 | 1.05 | 1.05 | 1.05 | 1.05 | 1.05 | 1.05 | 1.05 | 1.05 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | — | — | — | -100% |
| Operating Profit CAGR | — | — | — | — |
| PAT CAGR | — | — | — | — |
| Share Price CAGR | +94% | +22% | -16% | -4% |
| ROE Average | 0% | 0% | 0% | 0% |
| ROCE Average | 0% | 0% | 0% | 0% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 20.21 | 20.21 | 20.21 | 20.21 | 20.21 | 13.31 | 10.38 | 0 | 0 | 0 |
| FII | 0 | 0 | 0 | 0 | 0 | 6.93 | 9.31 | 16.99 | 16.99 | 16.99 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 79.79 | 79.79 | 79.79 | 79.79 | 79.79 | 79.76 | 80.31 | 83.01 | 83.01 | 83.01 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.14 | 0.11 | 0 | 0 | 0 |
| FII | 0 | 0 | 0 | 0 | 0 | 0.07 | 0.1 | 0.18 | 0.18 | 0.18 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.84 | 0.84 | 0.84 | 0.84 | 0.84 | 0.84 | 0.84 | 0.87 | 0.87 | 0.87 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.05 | 1.05 | 1.05 | 1.05 | 1.05 | 1.05 | 1.05 | 1.05 | 1.05 | 1.05 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.